New York State Common Retirement Fund Nektar Therapeutics Transaction History
New York State Common Retirement Fund
- $74.6 Billion
- Q4 2024
A detailed history of New York State Common Retirement Fund transactions in Nektar Therapeutics stock. As of the latest transaction made, New York State Common Retirement Fund holds 18,800 shares of NKTR stock, worth $11,844. This represents 0.0% of its overall portfolio holdings.
Number of Shares
18,800
Previous 18,800
-0.0%
Holding current value
$11,844
Previous $24,000
29.17%
% of portfolio
0.0%
Previous 0.0%
Shares
25 transactions
Others Institutions Holding NKTR
# of Institutions
154Shares Held
130MCall Options Held
92.7KPut Options Held
4.9K-
Black Rock Inc. New York, NY15.2MShares$9.55 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.3MShares$7.77 Million0.0% of portfolio
-
Samlyn Capital, LLC New York, NY9.67MShares$6.09 Million0.14% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT7.81MShares$4.92 Million0.37% of portfolio
-
Acadian Asset Management LLC Boston, MA7.2MShares$4.54 Million0.02% of portfolio
About NEKTAR THERAPEUTICS
- Ticker NKTR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 187,404,992
- Market Cap $118M
- Description
- Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...